• Accueil
  • /
  • All the itineraries of the Valley

All the itineraries of the Valley

  • Sort by
  • Start
  • Length
  • Duration

Refine your search

Length of route (km)

0 155

Cumulative ascent (m)

0 5300
Hiking trail B01: The vineyard hills
See the route

Hiking trail B01: The vineyard hills

Duration Half-day Length 7 Km Vertical rise 400 m Difficulty Challenging Departing from Barembach
From a use of low plots creating an open almost landscaped setting, the territory underwent a gradual abandon of terraced meadows and the bottom of the valley then harvested areas.
Hiking trail CDF11: Tour of Ban de la Roche
See the route

Hiking trail CDF11: Tour of Ban de la Roche

Duration 3h Length 8 Km Vertical rise 314 m Difficulty Intermediate Departing from Bellefosse
Bellefosse, Béfoss in patois, was part of the former Ban de la Roche fiefdom which became a Protestant land with seven other villages including Rothau and Fourday after the Reform.
Hiking trail CDF12 : The upper Bruche valley
See the route

Hiking trail CDF12 : The upper Bruche valley

Duration All day Length 19 Km Vertical rise 840 m Difficulty Expert Departing from Bellefosse
A woodland trail on the paths and forest roads around the CĂ´te de Plaine within the Vosges and Alsace with the highlight being the Chatte Pendue peaking at 899m.
Hiking trail CDF06: Tour of the Champ du Feu
See the route

Hiking trail CDF06: Tour of the Champ du Feu

Duration Half-day Length 12 Km Vertical rise 350 m Difficulty Intermediate Departing from Belmont
Champ du Feu is the highest point in Bas-Rhin at 1099m. Its high-altitude grassland and domed peatlands create a natural space that is fragile and exceptional in equal measure.
Hiking trail CDF03 : In the land of knuckles
See the route

Hiking trail CDF03 : In the land of knuckles

Duration Half-day Length 9 Km Vertical rise 300 m Difficulty Intermediate Departing from Belmont
Belle randonnée de difficulté moyenne, qui alterne pâtures et tronçons ombragés, sur les traces des légendes de sorcellerie du Ban de la Roche.